Many studies have demonstrated that in wild mice with drug-induced colitis, the injection of FXR agonists may considerably reduce intestinal inflammation, block the reduction of cup cells, repair the damaged intestinal mucosal barrier, reduce intestinal permeability, and therefore ameliorate colitis. The gene discussed is NR1H4; the disease is colitis.